James George Robinson, Director at NYMOX PHARMACEUTICAL CORP (NYMX), bought 8,400 shares at $1.77 ($15K) on 2019-05-30, disclosed to the SEC on 2019-05-31.
Open-market purchase of $15k NYMX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.76 | 7,700 | $14K | 91.6% |
| 2 | $1.77 | 100 | $177 | 1.2% |
| 3 | $1.77 | 600 | $1K | 7.2% |
| Total | $1.76 avg | 8,400 | $15K | 100% |
| Filing → |
| NYMX | BUY | 2022-05-06 | $3.8M | — | Filing → |
| NYMX | BUY | 2021-04-27 | $83K | — | Filing → |
| NYMX | BUY | 2019-07-12 | $12K | — | Filing → |